These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9500797)

  • 1. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy.
    Tenner-Racz K; Stellbrink HJ; van Lunzen J; Schneider C; Jacobs JP; Raschdorff B; Grosschupff G; Steinman RM; Racz P
    J Exp Med; 1998 Mar; 187(6):949-59. PubMed ID: 9500797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic HIV infection is characterized by rapid turnover of HIV RNA in plasma and lymph nodes but not of latently infected lymph-node CD4+ T cells.
    Stellbrink HJ; van Lunzen J; Hufert FT; Fröschle G; Wolf-Vorbeck G; Zöllner B; Albrecht H; Greten H; Racz P; Tenner-Racz K
    AIDS; 1997 Jul; 11(9):1103-10. PubMed ID: 9233456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patient.
    Orenstein JM; Feinberg M; Yoder C; Schrager L; Mican JM; Schwartzentruber DJ; Davey RT; Walker RE; Falloon J; Kovacs JA; Miller KD; Fox C; Metcalf JA; Masur H; Polis MA
    AIDS; 1999 Nov; 13(16):2219-29. PubMed ID: 10563707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlymphoid reservoirs of HIV replication in children with chronic-progressive disease.
    Brodie SJ
    J Leukoc Biol; 2000 Sep; 68(3):351-9. PubMed ID: 10985251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells.
    Gray CM; Lawrence J; Ranheim EA; Vierra M; Zupancic M; Winters M; Altman J; Montoya J; Zolopa A; Schapiro J; Haase AT; Merigan TC
    AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1357-69. PubMed ID: 11018855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression.
    Orenstein JM; Bhat N; Yoder C; Fox C; Polis MA; Metcalf JA; Kovacs JA; Falloon J; Walker RE; Masur H; Lane HC; Davey RT
    AIDS; 2000 Aug; 14(12):1709-15. PubMed ID: 10985306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals.
    Blackbourn DJ; Mackewicz CE; Barker E; Hunt TK; Herndier B; Haase AT; Levy JA
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13125-30. PubMed ID: 8917555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue.
    Ruiz L; van Lunzen J; Arno A; Stellbrink HJ; Schneider C; Rull M; Castellà E; Ojanguren I; Richman DD; Clotet B; Tenner-Racz K; Racz P
    AIDS; 1999 Jan; 13(1):F1-8. PubMed ID: 10207538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node expansion of CD4+ lymphocytes during antiretroviral therapy.
    Lafeuillade A; Chouraqui M; Hittinger G; Poggi C; Delbeke E
    J Infect Dis; 1997 Nov; 176(5):1378-82. PubMed ID: 9359743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.
    Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J
    Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus.
    Mueller BU; Sei S; Anderson B; Luzuriaga K; Farley M; Venzon DJ; Tudor-Williams G; Schwartzentruber DJ; Fox C; Sullivan JL; Pizzo PA
    J Pediatr; 1996 Sep; 129(3):410-8. PubMed ID: 8804331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
    Hengge UR; Borchard C; Esser S; Schröder M; Mirmohammadsadegh A; Goos M
    AIDS; 2002 Jan; 16(2):151-60. PubMed ID: 11807298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring responses to antiretroviral treatment in human immunodeficiency virus type 1 (HIV-1)-infected patients by serial lymph node aspiration.
    Bürgisser P; Spertini F; Weyrich-Suter C; Pagani JL; Meylan PR
    J Infect Dis; 1997 May; 175(5):1202-5. PubMed ID: 9129086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease.
    Wong CS; Buckner CM; Lage SL; Pei L; Assis FL; Dahlstrom EW; Anzick SL; Virtaneva K; Rupert A; Davis JL; Zhou T; Laidlaw E; Manion M; Galindo F; Anderson M; Seamon CA; Sneller MC; Lisco A; Deleage C; Pittaluga S; Moir S; Sereti I
    Front Immunol; 2021; 12():752782. PubMed ID: 34938286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of a combination of three reverse transcriptase inhibitors in HIV-1 infection.
    Lafeuillade A; Poggi C; Djediouane A; Chollet L; Profizi N; Sayada C
    Antivir Ther; 1997 Dec; 2(4):219-27. PubMed ID: 11327441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover.
    Anthony KB; Yoder C; Metcalf JA; DerSimonian R; Orenstein JM; Stevens RA; Falloon J; Polis MA; Lane HC; Sereti I
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):125-33. PubMed ID: 12794543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
    Bart PA; Rizzardi GP; Tambussi G; Chave JP; Chapuis AG; Graziosi C; Corpataux JM; Halkic N; Meuwly JY; Munoz M; Meylan P; Spreen W; McDade H; Yerly S; Perrin L; Lazzarin A; Pantaleo G
    AIDS; 2000 Sep; 14(13):1887-97. PubMed ID: 10997391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly active antiretroviral therapy for two years.
    Zhou HY; Zheng YH; Zhang CY; Chen J; He Y; Ding PP; Li H
    Viral Immunol; 2007; 20(1):180-7. PubMed ID: 17425432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study.
    Bart PA; Meuwly JY; Corpataux JM; Yerly S; Rizzardi P; Fleury S; Munoz M; Knabenhans C; Welbon C; Pantaleo G; Meylan PR
    AIDS; 1999 Aug; 13(12):1503-9. PubMed ID: 10465074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.